City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumors. Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope...
New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 27.19 | 29.1 | 26.74 | 2810 | 28.45591808 | DE |
156 | 0 | 0 | 4.639 | 29.1 | 3.05 | 850 | 18.88648565 | DE |
260 | 0 | 0 | 4.4475 | 29.1 | 1.9218 | 481 | 13.82191157 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.